Bulletin
Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

Repligen Corp.

NAS: RGEN

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Repligen Corp.

Before the Bell

RGEN
/zigman2/quotes/210324360/composite

$

185.30

Change

0.00 0.00%

Volume

Volume 142

Feb 1, 2023, 8:00 a.m.

Real time quotes

/zigman2/quotes/210324360/composite

Previous close

$ 185.30

$ 185.30

Change

+5.13 +2.85%

Day low

Day high

$178.48

$185.57

Open
Open: 181.44

52 week low

52 week high

$137.21

$262.26

Open

Market cap

$10.00B

Average volume

573,080

P/E ratio

64.18

Rev. per Employee

$432,665

EPS

2.89

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rgen

MarketWatch News on RGEN

  3. 10 Stocks Driving the Biotech Resurgence

    7:49 a.m. Aug. 18, 2022

    - Barron's Online

  4. Repligen stock price target raised to $275 from $213 at UBS

    7:54 a.m. Aug. 5, 2022

    - Tomi Kilgore

  5. Repligen started at buy with $213 stock price target at UBS

    8:20 a.m. July 20, 2022

    - Tomi Kilgore

  7. Repligen stock price target cut to $230 from $320 at Stifel Nicolaus

    8:01 a.m. Feb. 18, 2022

    - Tomi Kilgore

  8. Repligen stock price target raised to $335 from $255 at KeyBanc Capital

    5:15 a.m. Sept. 17, 2021

    - Tomi Kilgore

  9. How a 53-Year-Old Growth Fund Takes the Long View

    2:05 p.m. Nov. 29, 2021

    - Barron's Online

  10. Repligen started at overweight with $241 stock price target at KeyBanc Capital

    7:03 a.m. Nov. 10, 2020

    - Tomi Kilgore

  12. Small-Cap ‘Darlings’ Are Perking Up in 2020

    10:47 a.m. Jan. 21, 2020

    - Barron's Online

  13. These 6 stocks in the S&P 1500 have more than doubled in 12 months

    6:28 a.m. July 13, 2019

    - Philip van Doorn

  15. Repligen started at overweight with $42 stock price target at J.P. Morgan

    7:28 a.m. Dec. 5, 2017

    - Tomi Kilgore

  16. Repligen stock fair value estimate raised to $47 from $42 at Janney

    10:26 a.m. June 23, 2017

    - Tomi Kilgore

  18. Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln

    6:01 a.m. June 23, 2017

    - Tomi Kilgore

  19. Repligen's stock halted for news pending

    5:58 a.m. June 23, 2017

    - Tomi Kilgore

  20. Repligen's stock was inactive premarket prior to trading halt

    5:59 a.m. June 23, 2017

    - Tomi Kilgore

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/rgen

Other News on RGEN

  1. Why Is Glaxo (GSK) Up 6.7% Since Last Earnings Report?

    11:31 a.m. Dec. 2, 2022

    - Zacks.com

  3. BIIB or RGEN: Which Is the Better Value Stock Right Now?

    11:40 a.m. Nov. 23, 2022

    - Zacks.com

  4. Is Repligen a Value Trap or a Value Opportunity?

    11:42 a.m. Nov. 17, 2022

    - GuruFocus.com

  5. Frank Sands' Top 3rd-Quarter Trades

    4:44 p.m. Nov. 9, 2022

    - GuruFocus.com

  6. Frank Sands Buys 2, Sells 3 in 3rd Quarter

    12:00 p.m. Nov. 9, 2022

    - GuruFocus.com

  7. BIIB vs. RGEN: Which Stock Is the Better Value Option?

    11:40 a.m. Nov. 7, 2022

    - Zacks.com

  9. 10-Q: REPLIGEN CORP

    3:37 p.m. Nov. 1, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  10. Repligen Corporation (RGEN) Q3 2022 Earnings Call Transcript

    12:17 p.m. Nov. 1, 2022

    - Seeking Alpha

  11. Repligen (RGEN) Q3 Earnings and Revenues Top Estimates

    7:45 a.m. Nov. 1, 2022

    - Zacks.com

  15. LGND vs. RGEN: Which Stock Is the Better Value Option?

    10:40 a.m. Oct. 21, 2022

    - Zacks.com

  18. REGN vs. RGEN: Which Stock Is the Better Value Option?

    10:40 a.m. Oct. 4, 2022

    - Zacks.com

  19. Repligen: Now Best Biotech Nearby Cap-Gain Prospect

    10:44 a.m. Sept. 27, 2022

    - Seeking Alpha

  20. Repligen partners with DRS daylight solutions

    3:12 p.m. Sept. 19, 2022

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/rgen

Press Releases on RGEN

  5. Repligen to Report Third Quarter 2022 Financial Results

    6:30 a.m. Oct. 12, 2022

    - GlobeNewswire

  8. Repligen To Host Investor Day 2022

    6:30 a.m. Aug. 24, 2022

    - GlobeNewswire

  9. Tuesday's ETF with Unusual Volume: EPS

    11:27 a.m. Aug. 2, 2022

    - MarketNewsVideo.com

  11. Repligen to Report Second Quarter 2022 Financial Results

    6:30 a.m. July 19, 2022

    - GlobeNewswire

  15. Repligen to Report First Quarter 2022 Financial Results

    6:30 a.m. April 13, 2022

    - GlobeNewswire

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.